The following industry-supported symposium is held in conjunction with the Diamond Headache Clinic Research & Educational Foundation Meeting.

LOCATION

The Westin Michigan Avenue Chicago
Great Lakes Grand Ballroom, 2nd Floor
Chicago, Illinois

DOWNLOADS

Slides

Additional Resources

Will be available directly following the activity.

FACULTY

Mark W. Green, MD, FAAN
Professor of Neurology, Anesthesiology, and Rehabilitation Medicine,

Director of Headache and Pain Medicine,

Vice Chair of Neurology,

Icahn School of Medicine at Mount Sinai

New York, New York

MERLE L. DIAMOND, MD

President, Managing Director,

Diamond Headache Clinic

Chicago, Illinois

ROBBIE BERRY
A chronic migraineur

AGENDA

12:15pm-1:15PM central

Welcome and Session Overview

Lunch

 

Migraine: Who, What, and How

Mark W. Green, MD, FAAN

 

Safety and Efficacy of Current and Emerging Therapies

Mark W. Green, MD, FAAN

 

A Patient’s Journey in Chronic Migraine

Merle L. Diamond, MD, and Robbie Berry

 

Clinical Decision Making

Merle L. Diamond, MD

 

Question and Answer Session

 

Adjournment

register now!

ACTIVITY AND CME INFORMATION

TARGET AUDIENCE

WORKSHOP DESCRIPTION

LEARNING OBJECTIVES

This activity is designed for headache specialists and primary care physicians. Other healthcare professionals who care for patients with headache may also benefit from participation in the educational activity.

 

Treating primary headache disorders can frustrate patients and confound their physicians. However, science is catching up. We’ll explore the complexity of the condition and the promise of new therapeutic approaches in an interactive update led by expert faculty: Merle L. Diamond, MD, and Mark W. Green, MD, FAAN. Incorporating 3D illustrations, clinical trial data, and strategies for reducing delays in diagnosis, the program will also feature a live interview with Robbie Berry, a chronic migraineur who will guide us through her treatment journey, providing personal insights into the patient experience.

Update on Migraine: Unmet Clinical Need, Best Practices, and New Understanding of Pathophysiology
Upon completion of this part of the activity, participants should be able to:

 

 

1.

Discuss the prevalence, epidemiology, and burden
of migraine.

2.

Develop optimal plans for acute and preventive treatment of migraine, incorporating pharmacologic and nonpharmacologic options as appropriate to the individual patient.

 

3.

Describe newly characterized mechanisms
of migraine pathophysiology.

 

LEARNING OBJECTIVES (CONT.)

A Practical Perspective to Diagnosing Headache and Emerging Therapies
Upon completion of this part of the activity, participants should be able to:

 

 

1.

Effectively communicate
with patients to identify and diagnose primary headache disorders, including but not limited to migraine and cluster.

2.

Analyze new clinical trial data addressing safety and efficacy of emerging treatments for primary headache disorders.

CREDIT DESIGNATION STATEMENT

ACCREDITATION STATEMENT

 

DISCLOSURE STATEMENT

Forefront Collaborative designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is currently being reviewed by the American Board of Psychiatry & Neurology (ABPN) for Part II CME MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

 

Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

 

Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). The disclosures will be listed in the activity handout.

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Forefront Collaborative complies with the Americans with Disabilities Act and will make every reasonable effort to accommodate your request. For special requests, please call Sydney Pate at 317.814.3160 prior to this activity.

 

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative.

 

630 W. Carmel Drive, Suite 260

Carmel, Indiana 46032

P 317.814.3126